[1]
A. T. Carvalho, P. Abreu, and M. José Sá, “Multiple Sclerosis Treatment with Natalizumab: Analysis of a Hospital-Based Cohort”, Acta Med Port, vol. 27, no. 4, pp. 437–443, Aug. 2014.